Breast Cancer Lumpectomy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The FDA has approved the optical imaging agent Lumisight and the Lumicell Direct Visualization System for use in fluorescence imaging in breast cancer.

Howard hechlerImaging drugs advisory committeeLumicell incLumicell direct visualization systemFluorescence guidanceBreast cancer lumpectomy